Lataa...
Active and Passive Vaccination against Hantavirus Pulmonary Syndrome with Andes Virus M Genome Segment-Based DNA Vaccine
Hantavirus pulmonary syndrome (HPS) is a rapidly progressing human disease with one of the highest case fatality rates (30 to 50%) of any acute viral disease known. There are no vaccines, effective antiviral drugs, or immunologics to prevent or treat HPS. In an attempt to develop HPS medical counter...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology
2003
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC224585/ https://ncbi.nlm.nih.gov/pubmed/12941899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.77.18.9894-9905.2003 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|